non-hodgkin lymphoma | Research | Treatment | 10 pages | source: Strahlentherapie und Onkologie | Added Apr 16, 2025
Low-dose radiotherapy for low-grade lymphoma: What are the outcomes?
This study investigated the effectiveness, side effects, and relapse patterns of patients with low-grade (indolent; painless) follicular lymphoma (FL) or marginal zone lymphoma (MZL) after low-dose radiotherapy (LDRT). This study concluded that LDRT is an effective treatment in patients with low-grade disease and a low tumor burden.
diabetes mellitus | Medivizor | source: Medivizor | Added Apr 16, 2025
Be Confident! Face Carb Counting Positively
“Have not seen this example of carbs before. I need to understand more. I am NID type 2 diabetic.” "I have type2 diabetes..I don’t understand too much about carbs..could send me a list of the amounts of carbs in food please…thanks.." Carbs and carb counting help people with diabetes keeperectile dysfunction | Research | 10 pages | source: The journal of sexual medicine | Added Apr 15, 2025
Using high sensitivity c-reactive protein to monitor response to tadalafil in patients with erectile dysfunction
This study aimed to evaluate if high-sensitivity C-reactive protein (hs-CRP) can be used to monitor the effectiveness of PD-5 inhibitors. This study found that lower hs-CRP before treatment is associated with better response to medication.
colorectal cancer | Research | 10 pages | source: PLOS ONE | Added Apr 15, 2025
BRAF mutation and survival rates in stage 2 or 3 colorectal cancer
This study investigated the role of the BRAF mutation (change) in survival of stage 2 and 3 colorectal cancer patients.
Researchers suggested that the BRAF mutation was associated with lower survival rates of patients with stage 2 and 3 colorectal cancer.
non-hodgkin lymphoma | Research | Treatment | 10 pages | source: Haematologica | Added Apr 14, 2025
Subcutaneous vs intravenous rituximab treatment for patients with diffuse large B-cell lymphoma
This study compared the effectiveness of rituximab (Rituxen) treatment when given subcutaneously or intravenously for patients with diffuse large B-cell lymphoma. The study concluded that subcutaneous rituximab is just as effective as intravenous rituximab, and has higher patient satisfaction.
diabetes mellitus | Medivizor | source: Medivizor | Added Apr 14, 2025
Diabetes and Innovation: Insulin Pump + CGM = Artificial Pancreas
E-health and mobile connectivity, coupled with powerful software, is hitting the diabetes community by storm. It's a whole new world out there in self-care for people with diabetes. Insulin Pumps Rather than giving yourself individual injections of insulin every time you need it, an insulin pump provides you with rapidcolorectal cancer | Research | 14 pages | source: PLOS ONE | Added Apr 13, 2025
Can cyclin D1 levels predict survival in colorectal cancer?
The authors evaluated the association between cyclin D1 level, overall survival and disease-free survival in colorectal cancer patients.
non-hodgkin lymphoma | Research | Treatment | 10 pages | source: American Journal of Hematology | Added Apr 12, 2025
Evaluating rituximab maintenance therapy for mantle cell lymphoma
This study investigated the effectiveness of rituximab (Rituxan) maintenance therapy (treatment that is meant to help a primary treatment succeed) in patients with mantle cell lymphoma. The study concluded that this therapy improved survival outcomes in these patients after stem cell transplantation.
diabetes mellitus | Medivizor | source: Medivizor | Added Apr 12, 2025
Being a Pancreas: Life with Type 1 Diabetes
The time, energy and intellectual capacity of being a pancreas is daunting. “I am often the only person around who needs to do complicated mathematical equations before eating anything, before going anywhere, before mowing my lawn, shoveling snow, taking a walk, or before going to sleep at night. Diabetes iscolorectal cancer | Research | 7 pages | source: International Journal of Colorectal Disease | Added Apr 11, 2025
Mucinous adenocarcinoma is an independent predictor of improved overall survival
This study examines the survival rates of patients with mucinous adenocarcinoma colon cancer.
